Press release archives - Medical/Pharmaceuticals

Subscribe to India PRwire Breaking News RSS Feed to instantly access 25 most recent press releases across our network. If you are only interested in Medical/Pharmaceuticals industry press releases, subscribe to our Medical/Pharmaceuticals RSS feed.

Thursday, 25th Oct 2012

RCC Laboratories shakes hands with ViruSure for India

Offering Biosafety Testing Expertise for India´s Biopharmaceutical Companies More...

  • Published on Oct 25, 12

Monday, 15th Oct 2012

Indian pharmaceutical professionals look to Southeast Asia to conduct clinical trials

CTSE 2012 conference gets experts from Southeast Asia and India together to forge new collaborations. Beleaguered by long delays and regulatory uncertainty in India many Indian pharmaceutical companies are joining the ranks of their MNC counterparts in taking their clinical trials to Southeast Asia. More...

  • Published on Oct 15, 12

Thursday, 11th Oct 2012

SGS Pharma To Set Up New Plant In Roorkee

SGS to invest US $1 million in Roorkee, plans to raise funds on Exhilway Private Capital Market More...

  • Published on Oct 11, 12

Thursday, 27th Sep 2012

Dr. Reddy's Announces the Launch of Montelukast Sodium Oral Granules

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair® (montelukast sodium) oral granules in the US market on September, 26, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr.Reddy's ANDA for Montelukast Sodium Oral Granules. More...

  • Published on Sep 27, 12

Monday, 24th Sep 2012

India's Most Admired Indo-American Cardiac Surgeon Dr Mukesh Hariawala Raises Protest Over Artificial heart's mockery

Healthcare Economist & Eminent Cardiac Surgeon lashes out at marketing Gimmicks played over Artificial Heart by His Contemporary Peers. More...

  • Published on Sep 24, 12
Granules India Awarded India's Most Admired Company in Exports & India's Most Admired Company in Bulk Drugs

Granules India Ltd., a fast growing pharmaceutical manufacturing Company, announced it has been recognized as India's Most Admired Company in Exports & India's Most Admired Company in Bulk Drugs at the 5th Annual Pharmaceutical Business Leadership Awards organized by Pharmaleaders in association with BSE, Pharmexcil and IBEF. More...

  • Published on Sep 24, 12

Friday, 21st Sep 2012

Yashoda Hospitals Establishes Milestone in Transplantation Surgery - Performs First Lung Transplant in AP

Yashoda Hospitals performed the first successful lung transplantation in Andhra Pradesh on Mrs. Archana Shedge, a 34-year old from Pune, taking the medical facilities in A.P. one step forward. More...

  • Published on Sep 21, 12

Thursday, 20th Sep 2012

Dr. Reddy's announces the Launch of Amoxicillin Tablets, Capsules, and Oral Suspension

Dr. Reddy's Laboratories (NYSE: RDY) announced today that is has launched Amoxicillin Tablets Capsules, and Oral Suspension, a bioequivalent generic version of Amoxil® (Amoxicillin) Tablets, Capsules, and Oral Suspension in the US Market on September 17, 2012. Amoxicillin Tablets (500 mg and 875 mg), Capsules (250 mg and 500 mg), and Oral Suspension (125 mg/5 ml, 200 mg/5... More...

  • Published on Sep 20, 12

Tuesday, 18th Sep 2012

ABLE, DUKE and OSHL conduct workshop on Meeting the Challenges of Developing New Anticancer Therapies

The Association of Biotechnology Led Enterprises (ABLE), the DUKE University and The Open Source Health Laboratories (OSHL) organized a workshop on Meeting the Challenges of Developing New Anticancer Therapies in New Delhi on September 17th that attracted interest and participation from public agencies and private companies. More...

  • Published on Sep 18, 12

Monday, 17th Sep 2012

Technologically Superior Iron Supplement for Indian Patients

Anemia and iron deficiency are significant public health problems in India, particularly among women and children. Recent figures suggest that nearly 50% of young Indian women are anemic. According to doctors, while the Indian diet is poor in iron content it is sadly rich in absorption inhibitors leading to low intake of iron coupled with poor absorption - compiled by Suha... More...

  • Published on Sep 17, 12
Raising the bar in Osteoporosis treatment

"ExAct Calcium" formulated by Premier Nutraceuticals Pvt Ltd, Mumbai raises the bar in the treatment of Osteoporosis. According to Suhas Wadwalkar, VP Corporate Affairs, ExAct Calcium is the latest approach to strengthen the osteoporotic bones and prevent fractures. More...

  • Published on Sep 17, 12

Saturday, 15th Sep 2012

PNPL - Innovation in Nutraceuticals

Premier Nutraceuticals Pvt Ltd (PNPL) is driven by one Passion, bound by one Mission and guided by one Vision, to be different. Suhas Wadwalkar, VP Corporate Affairs says "The difference is noticed in our selection of molecules, its quality matching the global standards, its world-class presentation, its creatively designed communication and ultimately in its better benefi... More...

  • Published on Sep 15, 12

Thursday, 13th Sep 2012

Mat On SEZs May Kill India's Potential As Global Manufacturer Of Low Cost Medicines

The new Direct Tax Code (DTC) that seeks to perpetuate the Minimum Alternate Tax (MAT) on Special Economic Zones (SEZs) is likely to cause serious damage to India's chances of emerging as the global manufacturing base for lower cost medicines. Introduced in the Union Budget 2011-12, the MAT on SEZs is proposed to be perpetuated under the DTC Bill. More...

  • Published on Sep 13, 12

Tuesday, 11th Sep 2012

BSE Award For "Best Return To Investors" at 5th Annual Pharmaceutical Leadership Awards 2012 Intensifies

Aanjaneya Lifecare, Divis Laboratories, TTK Healthcare, Ajanta Pharma in the race for the prestigious title as India votes to choose the company which has maximized their Returns on Investments More...

  • Published on Sep 11, 12

Monday, 3rd Sep 2012

Wockhardt launches generic version of anti-depressant drug Wellbutrin® SR

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 100 mg, 150 mg and 200 mg 12-Hr extended release tablets of Bupropion HCl which is used in the treatment of depression. More...

  • Published on Sep 3, 12